ROSA NIAZOV, M.D.; JUDITH BAR-YOCHAI, M.D.; JOSEPH ALCALAY, M.D.; LEON ALKALAY, M.D., D.G.M.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Vasko and associates (1) have recently reported the alteration in furosemide absorption in patients with decompensated congestive heart failure. We have recently completed a clinical trial involving 20 bedridden patients with severe decompensated congestive heart failure. The patients were treated at home with the sodium salt of furosemide given orally in liquid form from the content of vials for injections, instead of with tablets. Before the trial all the patients had frequently been hospitalized because of severe congestion or pulmonary edema. During our study, over 36 months, 10 patients did not require hospitalization at all, 9 were
NIAZOV R, BAR-YOCHAI J, ALCALAY J, ALKALAY L. Oral Liquid Furosemide in Congestive Heart Failure. Ann Intern Med. ;103:477. doi: 10.7326/0003-4819-103-3-477_1
Download citation file:
Published: Ann Intern Med. 1985;103(3):477.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use